Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs directed at increasing the horizons of cytokine-based immunotherapy, especially for cancers where procedure selections remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/david-sacks-confirms-white-house-support/